GlassScriptPhysician profile
Stephen R Price
NPI 1609840438
$642.62
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $170 · 2022: $65.58 · 2023: $282 · 2024: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $408.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $407.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $381.52 | 2021-2024 | |
| Idorsia Pharmaceuticals US INC | $125.00 | 2023 | Quviviq |
| Kci USA, INC. | $38.78 | 2023 | V.A.C. Dermatac, Promogran Prisma, Activ.A.C. |
| Smith+Nephew, INC. | $30.08 | 2021-2022 | |
| Melinta Therapeutics, LLC | $24.99 | 2023 | Kimyrsa |
| Hydrofera LLC | $22.77 | 2022 | |
| Solventum Corporation | $19.48 | 2024 | Activ.A.C. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Price listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.